Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO₂

References

• Atherton JC, Cockayne A, Balsitis M, Kirk GE, Hawley CJ, Spiller RC. Detection of the intragastric sites at Helicobacter pylori evades treatment with amoxicillin and cimetidine. Gut 1995; 36: 670–4
   PubMed Web of Science ®Google Scholar
• Axon AT. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 16–23
   Web of Science ®Google Scholar
• Berton M, Benimetskaya L, Allemann E, Stein CA, Gurny R. Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization. Eur J Pharm Biopharm 1999; 47: 119–23
   PubMed Web of Science ®Google Scholar
• Blaser M. Ecology of helicobacter pylori in the human stomach. J Clin Invest 1997; 100: 759–62
   PubMed Web of Science ®Google Scholar
• Buzas GM, Szekely E. Eradication of Helicobacter pylori in peptide ulcer patients. Orv Hetil 1999; 140: 121–4
   PubMedGoogle Scholar
• Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology – Towards biomedical applications. Adv Drug Delivery Rev 2008; 60: 299–27
   PubMed Web of Science ®Google Scholar
• Chadha R, Kashid N, Jain DV. Kinetic studies of the degradation of an aminopenicillin antibiotic in aqueous solution using heat conduction microcalorimerty. J Pharm Pharmcol 2003; 55: 1495–503
   PubMed Web of Science ®Google Scholar
• Chen AZ, Pu XM, Kang YQ, Liao L, Yao YD, Yin GF. Preparation of 5-fluorouracil-poly(L-lactide) microparticles using solution-enhanced dispersion by supercritical CO2, Macromol. Rapid Commun 2006; 27: 1254–59
   Web of Science ®Google Scholar
• Chen AZ, Pu XM, Kang YQ, Liao L, Yao YD, Yin GF. Study of poly(L-lactide) microparticles based on supercritical CO2. J Mater Sci – Mater Med 2007; 18: 2339–45
   PubMed Web of Science ®Google Scholar
• Chickering D, Jacob J, Mathiowitz E. Bioadhesive microspheres: II. Characterization and evaluation of bioadhesion involving hard, bioerodiable polymers and soft tissue. Reactive Polym 1995; 25: 198–206
   Google Scholar
• Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993; 37: 1506–9
   PubMed Web of Science ®Google Scholar
• Erach PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC. The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother 1997; 39: 5–12
   PubMed Web of Science ®Google Scholar
• Forman D, Newell F, Fullerton J, Yarnell A, Stacey N, Wald S. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br Med J 1991; 302: 302–5
   PubMed Web of Science ®Google Scholar
• Forman D, Webb P, Personnet JH. Pylori and gastric cancer. Lancet 1994; 343: 243–4
   PubMed Web of Science ®Google Scholar
• Giacomo F, Marinano L, Silvana M, Domenico S, Gaetano G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001; 22: 2857–65
   PubMed Web of Science ®Google Scholar
• Gisbert J, Pajares J. Helicobacter pylori therapy: First-line options and rescue regimen. Dig Dis 2001; 19: 134–43
   PubMed Web of Science ®Google Scholar
• Hakuta Y, Hayashi H, Arai K. Fine particle formation using supercritical fluids. Solid State Mater Sci 2003; 7: 341–51
   Google Scholar
• Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihygrate. Int J Pharm 1992; 86: 79–88
   Web of Science ®Google Scholar
• Hombreiro-Perez M, Siepmann J, Zinutti C, Lamprecht A, Ubrich N, Hoffman M. Nondegradable microparticles containing a hydrophilic and/or a lipophilic drug: Preparation, characterization and drug release modeling. J Control Rel 2003; 88: 413–28
   PubMed Web of Science ®Google Scholar
• Hombreiro-Perez M, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffma M. The preparation and evaluation of poly(ϵ"-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Rel 2000; 65: 429–38
   PubMed Web of Science ®Google Scholar
• Jenks P, Edwards D. Metronidazole resistance in Helicobacter pylori. Int J Antimicrob Agents 2002; 19: 1–7
   PubMed Web of Science ®Google Scholar
• Jung J, Perrut M. Particle design using supercritical fluids: Literature and patent survey. J Supercrit Fluids 2001; 20: 179–19
   Web of Science ®Google Scholar
• Kang YQ, Yin GF, Ouyang P, Huang ZB, Yao YD, Liao XM, Chen AZ, Pu XM. Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J Colloid Interface Sci 2008; 322: 87–94
   PubMed Web of Science ®Google Scholar
• Kawabami E, Ogata SK, Portorreal AC. Triple therapy with clarithromycin amoxicillin and omeprazole for Helicobacter pylori in eradication in children and adolescents. Arq Gastroenterol 2001; 38: 203–6
   PubMedGoogle Scholar
• Korsemeyer R, Gurny R, Peppas N. Mechnisums of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35
   Web of Science ®Google Scholar
• Kwon D, Kim J, Lee M, Yamaoka M, Kato M, Osato M, El-Zaatari F, Graham D. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 2000; 44: 3203–5
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bowstra JA, Tukker JJ, Junginger HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. J Contr Rel 1990; 13: 51–62
   Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm 1992; 78: 43–8
   Web of Science ®Google Scholar
• Lin CK, Hsu PI, Lai KH. One-week quadruple therapy is an effective salvage regiment for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol 2002; 34: 547–51
   PubMed Web of Science ®Google Scholar
• Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Rel 1998; 52: 109–18
   PubMed Web of Science ®Google Scholar
• Magraud F, Lamouliatte H. Helicobacter pylori and duodenal ulcers. Dig Dis Sci 1992; 37: 769–72
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Mégraud F, O’Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. European Helicobacter pylori study group (EHPSG). Current concepts in the management of Helicobacter pylori infection – The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Theor 2002; 16: 167–80
   PubMed Web of Science ®Google Scholar
• Martín A, Cocero MJ. Micronization processes with supercritical fluids: Fundamentals and mechanisms. Adv Drug Delivery Rev 2008; 60: 339–50
   PubMed Web of Science ®Google Scholar
• Mascher C, Kikuta C. Determination of amoxicillin in human serum and plasma by high-performance liquid chromatography and on-line postcolumn derivatisation. J Chromatogr A 1998; 182: 221–6
   Web of Science ®Google Scholar
• Munday DL, Cox PL. Compressed xanthan and karaya gum matrices hydration, erosion and drug release mechanisms. Int J Pharma 2000; 203: 179–92
   PubMed Web of Science ®Google Scholar
• Nagahara N, Akiyama Y, Nako M, Tada M, Kitano M, Ogawa Y. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agent Chemother 1998; 42: 2492–4
   PubMed Web of Science ®Google Scholar
• Nixon JR. Release characterization of microcapsules. Biomedical applications of microcapsulation, F Lim. CRC Press, Boca Raton, FL 1983; 1227
   Google Scholar
• Ogwal S, Xide TU. Bioavailability and stability of erythromycin delayed release tablets. Afr Health Sci 2001; 2: 90–6
   Google Scholar
• Osato M, Reddy S, Reddy R, Penland R, Malaty H, Graham D. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 2001; 161: 1217–20
   PubMed Web of Science ®Google Scholar
• Patel JK, Chavda JR. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy. J. Microencapsulat 2009; 26: 365–76
   PubMed Web of Science ®Google Scholar
• Patel JK, Patel MM. Stomach specific anti-Helicobacter Pylori therapy-preparation and evaluation of amoxicillin loaded chitosan mucoadhesive microspheres. Curr Drug Deliv 2007; 4: 41–51
   PubMedGoogle Scholar
• Ranga R, Devi KD, Buri P. Cellulose matrices for zeroorder release of soluble drugs. Drug Dev Ind Pharm 1988; 14: 2299–2320
   Web of Science ®Google Scholar
• Reverchon E. Supercritical antisolvent precipitation of micro- and nano-particles. J Supercrit Fluids 1999; 15: 1–21
   Web of Science ®Google Scholar
• Ritger P L, Peppas NA. A simple equation for description of solute release: I. Fickian and non-Fickian release from nonswellable devices in the form of slabs, spheres, cylinders or discs. J Control Rel 1987a; 5: 23–36
   Google Scholar
• Ritger P L, Peppas NA. A simple equation for description of solute release: II. Fickian and anomalous release from swellable devices. J Control Rel 1987b; 5: 37–42
   Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004; 274: 1–33
   PubMed Web of Science ®Google Scholar
• Suleymanlar I, Tuncer M, Tugrul Sezer M, Erttugrul C, Sarikaya M, Fevzi Ersoy E, Isitan F, Yakupoglu G, Suleymanlar G. Response to triple treatment with omeprazole, amoxicillin and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 1999; 15: 79–81
   PubMedGoogle Scholar
• Vakil N, Cutler A. Ten-day triple therapy with ranitidine, bismuthcitrate, amoxicillin and clarithromycin in eradicating Helicobacter pylori. Am J Gastroenterol 1999; 94: 1197–9
   PubMed Web of Science ®Google Scholar
• Vega-Gonzalez A, Subra-Paternault P, Lopez-Periago AM, Garcia-Gonzalez CA, Domingo C. Supercritical CO2 antisolvent precipitation of polymer networks of L-PLA, PMMA and PMMA/PCL blends for biomedical applications. Eur Polym J 2008; 44(4): 1081–94
   Web of Science ®Google Scholar
• Wang YL, Dave RN, Pfeffer R. Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process. J Supercritic Fluids 2004; 28: 85–99
   Web of Science ®Google Scholar
• Wang YL, Pfeffer R, Dave R, Enick R. Polymer encapsulation of fine particles by a supercritical antisolvent process. AIChE J 2005; 51: 440–55
   Web of Science ®Google Scholar
• Wang YL, Wang YP, Yang J, Pfeffer R, Dave R, Michniak B. The application of a supercritical antisolvent process for sustained drug delivery. Powder Technol 2006; 164: 94–102
   Web of Science ®Google Scholar
• Warren JR, Marshall B. Unified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321: 1273–5
   Google Scholar
• Wu H, Shi XD, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother 2000; 46: 121–3
   PubMed Web of Science ®Google Scholar